Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.29 trillion and total revenue of $115.96 billion.
Market Cap
1.29T
Revenue
115.96B
Profits
-37.98B
PE Ratio
n/a
Profit Margin
-32.75%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.87B | 0.26% | 1,214,098 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.07B | -0.26% | 721,110 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 72.70B | -0.25% | 17,727,824 | 2.23B |
| 4 | ARGX | argenx SE | 59.55B | -1.86% | 426,481 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 41.50B | -0.84% | 631,811 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.88B | -1.10% | 2,124,868 | - |
| 7 | RPRX | Royalty Pharma plc | 33.15B | -1.49% | 2,804,338 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.99B | -2.04% | 1,481,714 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.60B | -3.66% | 9,272,934 | 7.53M |
| 10 | INSM | Insmed Incorporated | 25.84B | -2.05% | 1,921,655 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.26B | -1.80% | 1,534,432 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.73B | -2.39% | 1,087,592 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.87B | -1.33% | 2,509,747 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.25B | -2.37% | 792,218 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.65B | -6.08% | 1,218,303 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.06B | -2.44% | 1,431,534 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.12B | -3.91% | 3,891,072 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.85B | -5.08% | 3,677,819 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 12.76B | -2.34% | 2,702,793 | 1.66B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.21B | -3.89% | 809,874 | 830.81M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 12.04B | -1.83% | 2,105,165 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.85B | -1.12% | 315,951 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.37B | -0.04% | 3,562,211 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.13B | -4.75% | 912,995 | 776.57M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.12B | -2.60% | 215,950 | 440.48M |
| 26 | TWST | Twist Bioscience Corporation | 9.94B | -3.71% | 2,133,953 | 431.80M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 9.60B | -5.40% | 969,616 | 105.00M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.46B | -6.82% | 2,555,515 | 669.50M |
| 29 | CYTK | Cytokinetics, Incorporated | 9.15B | -2.63% | 2,050,951 | 67.67M |
| 30 | IBRX | ImmunityBio, Inc. | 9.15B | -7.10% | 13,954,481 | 165.79M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 8.98B | -4.39% | 513,226 | 281.99M |
| 32 | CAI | Caris Life Sciences, Inc. | 8.94B | 0.57% | 4,359,812 | 989.61M |
| 33 | PCVX | Vaxcyte, Inc. | 8.41B | -4.28% | 1,650,416 | - |
| 34 | ABVX | ABIVAX Société Anonyme | 8.32B | -4.23% | 2,637,352 | 5.33M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.94B | -3.63% | 2,119,984 | 799.54M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 7.88B | -6.16% | 1,005,314 | 7.46M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.77B | -4.13% | 918,770 | - |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.30B | -3.98% | 3,535,787 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 7.13B | -7.37% | 3,652,868 | - |
| 40 | BLTE | Belite Bio, Inc | 6.79B | -3.81% | 153,825 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.76B | -1.04% | 696,414 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.50B | -5.63% | 830,945 | 6.23M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.07B | -2.62% | 2,492,617 | - |
| 44 | ORKA | Oruka Therapeutics, Inc. | 5.95B | -4.89% | 1,992,979 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.03% | 242,198 | 290.54M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.80B | -2.27% | 739,145 | 618.07M |
| 47 | TVTX | Travere Therapeutics, Inc. | 5.64B | -0.75% | 1,713,844 | 591.33M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.45B | -3.74% | 2,330,315 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 5.39B | -5.54% | 2,362,536 | 13.39M |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.23B | -4.99% | 1,187,399 | 1.90M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.20B | -5.49% | 1,101,130 | 1.01B |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.06B | -6.62% | 2,712,784 | - |
| 53 | ERAS | Erasca, Inc. | 4.88B | -10.32% | 4,424,782 | - |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.86B | 1.96% | 15,732,166 | - |
| 55 | MANE | Veradermics, Incorporated | 4.84B | -2.00% | 754,310 | - |
| 56 | IOVA | Iovance Biotherapeutics, Inc. | 4.62B | -4.23% | 15,917,342 | 324.97M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.46B | -7.77% | 2,607,142 | - |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 4.38B | -3.71% | 1,306,067 | 1.14B |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.12B | -4.23% | 4,957,193 | 53.81M |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.11B | -12.73% | 1,114,053 | 148.00K |
| 61 | ABCL | AbCellera Biologics Inc. | 3.99B | -2.69% | 3,854,932 | 66.17M |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.95B | -6.82% | 4,708,163 | 10.35M |
| 63 | CELC | Celcuity Inc. | 3.91B | -4.89% | 739,445 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.85B | -5.69% | 464,894 | 890.79M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.61B | -5.67% | 2,238,181 | 234.13M |
| 66 | LEGN | Legend Biotech Corporation | 3.58B | -1.02% | 2,409,417 | 1.27B |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | -6.47% | 3,173,719 | 7.50M |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.38B | -4.36% | 1,550,859 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.36B | -1.79% | 1,561,372 | 117.00M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -5.04% | 2,512,213 | 463.98M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.27B | -5.28% | 1,914,177 | 3.60M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | -3.62% | 674,306 | 606.33M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.03B | -5.31% | 2,636,265 | - |
| 74 | ZLAB | Zai Lab Limited | 2.97B | 0.11% | 791,636 | 449.61M |
| 75 | QURE | uniQure N.V. | 2.97B | -5.57% | 1,173,507 | 18.67M |
| 76 | MBX | MBX Biosciences, Inc. | 2.79B | -6.60% | 352,410 | - |
| 77 | IMNM | Immunome, Inc. | 2.75B | -5.86% | 2,270,645 | 4.02M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 2.71B | -2.74% | 2,265,377 | 7.12M |
| 79 | PGEN | Precigen, Inc. | 2.66B | -5.70% | 5,563,948 | 85.72M |
| 80 | GPCR | Structure Therapeutics Inc. | 2.56B | -2.60% | 1,400,802 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.54B | -3.49% | 541,832 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.48B | -6.97% | 1,364,031 | 36.77M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.44B | -7.13% | 4,235,974 | 158.00K |
| 84 | BEAM | Beam Therapeutics Inc. | 2.44B | -6.02% | 1,899,921 | 156.04M |
| 85 | VRDN | Viridian Therapeutics, Inc. | 2.43B | -3.12% | 2,857,645 | 71.13M |
| 86 | VERA | Vera Therapeutics, Inc. | 2.38B | -8.85% | 2,018,428 | - |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -8.54% | 1,479,343 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.36B | -2.53% | 1,080,649 | 959.90M |
| 89 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -4.16% | 3,888,918 | - |
| 90 | PHVS | Pharvaris N.V. | 2.32B | -6.05% | 654,290 | - |
| 91 | OCUL | Ocular Therapeutix, Inc. | 2.20B | -4.76% | 2,089,390 | 52.06M |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.62% | 787,299 | 311.51M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.17B | -1.12% | 2,595,479 | 512.28M |
| 94 | PVLA | Palvella Therapeutics, Inc. | 2.15B | -5.42% | 180,604 | - |
| 95 | GENB | Generate Biomedicines, Inc. | 2.12B | -5.38% | 1,426,008 | 26.48M |
| 96 | BHVN | Biohaven Ltd. | 2.06B | -7.95% | 2,742,904 | - |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.06B | -5.12% | 1,349,816 | - |
| 98 | LKFT | Lakefront Biotherapeutics NV | 2.04B | 1.76% | 636,675 | 1.13B |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -2.23% | 752,478 | 98.34M |
| 100 | URGN | UroGen Pharma Ltd. | 2.03B | -2.64% | 1,298,453 | 188.73M |
| 101 | NUVB | Nuvation Bio Inc. | 2.00B | -6.39% | 4,606,056 | 169.90M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -8.94% | 3,757,657 | 1.97B |
| 103 | MESO | Mesoblast Limited | 1.99B | -3.96% | 451,523 | 120.25M |
| 104 | VCEL | Vericel Corporation | 1.99B | -3.56% | 433,961 | 306.30M |
| 105 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | -8.64% | 23,670,618 | 54.86M |
| 106 | KOD | Kodiak Sciences Inc. | 1.98B | -6.75% | 1,053,149 | - |
| 107 | NKTR | Nektar Therapeutics | 1.97B | -5.43% | 1,843,823 | 54.59M |
| 108 | ZYME | Zymeworks Inc. | 1.95B | -0.25% | 647,748 | 37.13M |
| 109 | ZBIO | Zenas BioPharma, Inc. | 1.93B | -10.35% | 525,138 | 1.00M |
| 110 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -1.21% | 1,549,775 | 208.78M |
| 111 | VIR | Vir Biotechnology, Inc. | 1.88B | -3.57% | 1,685,268 | 303.23M |
| 112 | FTRE | Fortrea Holdings Inc. | 1.86B | -4.45% | 1,067,781 | 2.68B |
| 113 | XNCR | Xencor, Inc. | 1.80B | -3.58% | 1,156,611 | 104.97M |
| 114 | SEPN | Septerna, Inc. | 1.79B | -4.78% | 509,720 | 98.88M |
| 115 | GHRS | GH Research PLC | 1.78B | -6.82% | 178,833 | - |
| 116 | NBTX | Nanobiotix S.A. | 1.75B | 0.26% | 126,953 | 38.27M |
| 117 | NVAX | Novavax, Inc. | 1.74B | -2.59% | 5,773,245 | 413.80M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.73B | -2.84% | 5,042,163 | 59.51M |
| 119 | COAG | Hemab Therapeutics Holdings, Inc. | 1.72B | -3.97% | 417,075 | - |
| 120 | KLRA | Kailera Therapeutics, Inc. | 1.70B | 2.66% | 1,631,764 | - |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.68B | -10.58% | 1,201,661 | 27.59M |
| 122 | ABSI | Absci Corporation | 1.67B | -9.01% | 4,721,171 | 1.56M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.64B | -17.70% | 745,549 | 20.00M |
| 124 | IMCR | Immunocore Holdings plc | 1.62B | -2.71% | 411,738 | 430.78M |
| 125 | TSHA | Taysha Gene Therapies, Inc. | 1.60B | -4.84% | 5,507,261 | 5.49M |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.60B | -9.15% | 1,102,779 | - |
| 127 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | -3.02% | 2,086,693 | 252.25M |
| 128 | MAZE | Maze Therapeutics, Inc. | 1.56B | -1.02% | 1,704,158 | 20.00M |
| 129 | ANAB | AnaptysBio, Inc. | 1.52B | -5.84% | 779,608 | 106.09M |
| 130 | OMER | Omeros Corporation | 1.50B | -1.47% | 1,349,575 | 38.42M |
| 131 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -0.07% | 1,206,020 | - |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.48B | -9.34% | 375,303 | 1.30M |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.47B | -7.66% | 66,333 | - |
| 134 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -4.74% | 5,712,615 | 717.00M |
| 135 | INVA | Innoviva, Inc. | 1.46B | -3.53% | 4,031,153 | 440.00M |
| 136 | AAPG | Ascentage Pharma Group International | 1.45B | -1.83% | 1,461 | 94.61M |
| 137 | BRVE | Braveheart Bio, Inc. | 1.41B | -9.11% | 521,815 | - |
| 138 | ORIC | ORIC Pharmaceuticals, Inc. | 1.38B | -1.26% | 1,717,561 | - |
| 139 | KARD | Kardigan, Inc. | 1.36B | -11.68% | 654,263 | - |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.36B | -10.07% | 954,771 | - |
| 141 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -4.10% | 727,069 | - |
| 142 | LTGO | Latigo Biotherapeutics, Inc. | 1.32B | -4.08% | 214,615 | - |
| 143 | AVLN | Avalyn Pharma Inc. | 1.32B | -8.57% | 252,042 | - |
| 144 | TRAX | First Tracks Biotherapeutics, Inc. | 1.31B | -10.65% | 659,443 | - |
| 145 | SVRA | Savara Inc. | 1.27B | -5.66% | 3,353,903 | - |
| 146 | LBRX | LB Pharmaceuticals Inc | 1.26B | -8.20% | 481,681 | - |
| 147 | DMRA | Damora Therapeutics, Inc. | 1.26B | -8.79% | 1,067,227 | - |
| 148 | REPL | Replimune Group, Inc. | 1.22B | -3.79% | 1,887,504 | - |
| 149 | IMTX | Immatics N.V. | 1.18B | -3.04% | 384,171 | 47.65M |
| 150 | VOR | Vor Biopharma Inc. | 1.15B | -11.95% | 2,764,311 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.14B | -4.91% | 179,280 | - |
| 152 | MGTX | MeiraGTx Holdings plc | 1.13B | -4.86% | 1,419,263 | 397.50M |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.10B | -3.59% | 2,003,354 | - |
| 154 | AKTS | Aktis Oncology, Inc. | 1.10B | -10.81% | 589,437 | 10.06M |
| 155 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -22.15% | 2,595,562 | - |
| 156 | ANRO | Alto Neuroscience, Inc. | 1.08B | -10.66% | 639,854 | - |
| 157 | MNKD | MannKind Corporation | 1.07B | -4.30% | 2,877,456 | 393.63M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.05B | -6.70% | 946,677 | - |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 1.01B | -5.63% | 1,175,822 | 28.73M |
| 160 | ANL | Adlai Nortye Group Ltd. | 1.01B | -5.12% | 218,130 | 18.06M |
| 161 | JANX | Janux Therapeutics, Inc. | 1.01B | -5.44% | 967,532 | 24.00M |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 994.79M | -11.05% | 255,191 | 99.00K |
| 163 | KURA | Kura Oncology, Inc. | 982.13M | -5.88% | 2,771,787 | 77.23M |
| 164 | ALMS | Alumis Inc. | 963.00M | -8.26% | 2,694,970 | 7.40M |
| 165 | ABUS | Arbutus Biopharma Corporation | 959.56M | -3.19% | 10,842,007 | 181.72M |
| 166 | HELP | Cybin Inc. | 951.24M | -5.03% | 1,850,372 | - |
| 167 | SLBT | SL Science Holding Limited | 946.64M | -1.19% | 30,830 | 3.27M |
| 168 | OBX | Obsidian Therapeutics, Inc. | 942.65M | -10.24% | 582,606 | - |
| 169 | SGP | SpyGlass Pharma, Inc. | 941.90M | -1.85% | 149,328 | - |
| 170 | APMD | Apnimed, Inc. | 936.28M | -11.84% | 858,154 | 115.12M |
| 171 | JBIO | Jade Biosciences, Inc. | 935.52M | -12.23% | 1,464,714 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 922.03M | -7.51% | 3,840,271 | - |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 916.61M | -5.50% | 3,172,481 | 41.47M |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 899.06M | -1.41% | 151,375 | 276.79M |
| 175 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 10,043,495 | 104.31M |
| 176 | ARDX | Ardelyx, Inc. | 867.17M | -3.87% | 6,279,819 | 450.89M |
| 177 | CADL | Candel Therapeutics, Inc. | 863.89M | -4.73% | 1,287,820 | - |
| 178 | SLDB | Solid Biosciences Inc. | 859.95M | -10.09% | 1,088,232 | - |
| 179 | IMMX | Immix Biopharma, Inc. | 852.75M | -7.09% | 1,168,238 | - |
| 180 | ATTO | Attovia Therapeutics, Inc. | 845.46M | -11.09% | 689,038 | 1.80M |
| 181 | FDMT | 4D Molecular Therapeutics, Inc. | 828.66M | -5.54% | 1,465,465 | 92.01M |
| 182 | AVTX | Avalo Therapeutics, Inc. | 820.54M | -7.33% | 1,111,198 | 59.00K |
| 183 | FTH | Faeth Therapeutics, Inc. | 815.27M | -5.54% | 435,049 | - |
| 184 | IVA | Inventiva S.A. | 807.61M | -5.48% | 2,133,042 | 7.94M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 805.73M | -3.57% | 1,328,074 | - |
| 186 | GERN | Geron Corporation | 796.67M | -5.34% | 10,925,293 | 204.56M |
| 187 | ETRA | Electra Therapeutics, Inc. | 795.26M | -6.98% | 875,390 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 784.65M | -1.20% | 164,559 | 109.82M |
| 189 | WVE | Wave Life Sciences, Inc. | 778.34M | -9.20% | 3,975,018 | 65.37M |
| 190 | ACRS | Aclaris Therapeutics, Inc. | 774.27M | -8.04% | 1,962,833 | 8.22M |
| 191 | DSGN | Design Therapeutics, Inc. | 773.51M | -6.08% | 738,275 | - |
| 192 | OLMA | Olema Pharmaceuticals, Inc. | 772.60M | -8.40% | 1,642,261 | - |
| 193 | PHAR | Pharming Group N.V. | 758.99M | -4.35% | 28,598 | 366.48M |
| 194 | VSTM | Verastem, Inc. | 740.81M | -2.27% | 1,936,675 | 87.53M |
| 195 | DBVT | DBV Technologies S.A. | 735.66M | -3.64% | 377,512 | 5.04M |
| 196 | ANNX | Annexon, Inc. | 733.67M | -7.42% | 2,423,554 | - |
| 197 | CLYM | Climb Bio, Inc. | 719.10M | -11.89% | 2,141,737 | - |
| 198 | BLSM | BlossomHill Therapeutics, Inc. | 710.07M | -11.52% | 219,658 | - |
| 199 | OABI | OmniAb, Inc. | 696.42M | -2.64% | 1,050,908 | 38.46M |
| 200 | MDXG | MiMedx Group, Inc. | 695.28M | -3.25% | 1,003,284 | 355.17M |
| 201 | SLN | Silence Therapeutics plc | 693.01M | -6.35% | 876,993 | 615.00K |
| 202 | NVCT | Nuvectis Pharma, Inc. | 686.49M | -8.39% | 169,190 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 672.22M | -2.25% | 735,894 | 136.07M |
| 204 | SGMT | Sagimet Biosciences Inc. | 647.69M | -6.04% | 1,115,925 | - |
| 205 | STTK | Shattuck Labs, Inc. | 638.31M | -2.15% | 1,386,490 | 1.00M |
| 206 | AURA | Aura Biosciences, Inc. | 624.30M | -6.67% | 1,037,128 | - |
| 207 | ALT | Altimmune, Inc. | 620.51M | -6.45% | 4,531,546 | 31.00K |
| 208 | NGNE | Neurogene Inc. | 618.95M | -7.95% | 276,187 | 925.00K |
| 209 | OCS | Oculis Holding AG | 616.70M | -6.72% | 143,773 | 1.45M |
| 210 | CBIO | Crescent Biopharma, Inc. | 607.35M | -13.69% | 727,683 | 11.88M |
| 211 | CTMX | CytomX Therapeutics, Inc. | 605.76M | -5.44% | 4,955,455 | 18.30M |
| 212 | VALN | Valneva SE | 601.98M | -3.64% | 14,687 | 163.30M |
| 213 | MNPR | Monopar Therapeutics Inc. | 599.93M | -7.50% | 89,336 | - |
| 214 | CRMD | CorMedix Inc. | 599.39M | -1.16% | 812,571 | 462.25M |
| 215 | MPLT | MapLight Therapeutics, Inc. | 598.55M | -0.83% | 538,957 | - |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 577.78M | -8.43% | 1,845,174 | 132.42M |
| 217 | ALLO | Allogene Therapeutics, Inc. | 576.97M | -2.34% | 5,965,945 | 4.64M |
| 218 | DRUG | Bright Minds Biosciences Inc. | 570.62M | -4.53% | 90,379 | - |
| 219 | PRME | Prime Medicine, Inc. | 556.84M | -11.58% | 3,334,199 | 4.07M |
| 220 | PHAT | Phathom Pharmaceuticals, Inc. | 554.82M | -9.99% | 1,045,233 | 239.66M |
| 221 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.37M | -5.13% | 662,592 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 530.15M | -6.31% | 98,687 | - |
| 223 | AUTL | Autolus Therapeutics plc | 519.02M | -3.94% | 1,442,556 | 117.39M |
| 224 | ARVN | Arvinas, Inc. | 511.97M | -7.99% | 761,366 | 316.70M |
| 225 | CAPR | Capricor Therapeutics, Inc. | 504.07M | -7.17% | 3,147,288 | 11.13M |
| 226 | INDP | Indaptus Therapeutics, Inc. | 502.32M | -5.51% | 624,670 | - |
| 227 | SCTX | Scribe Therapeutics Inc. | 502.26M | -5.49% | 532,701 | 33.30M |
| 228 | OVID | Ovid Therapeutics Inc. | 501.92M | -6.88% | 2,635,321 | 1.58M |
| 229 | PROK | ProKidney Corp. | 498.83M | -9.84% | 1,440,852 | 818.00K |
| 230 | RGNX | REGENXBIO Inc. | 495.10M | -7.98% | 1,113,283 | 174.48M |
| 231 | TECX | Tectonic Therapeutic, Inc. | 488.34M | -5.74% | 207,425 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 488.04M | -5.82% | 275,248 | 74.85M |
| 233 | ENTX | Entera Bio Ltd. | 486.53M | -5.70% | 858,158 | 42.00K |
| 234 | PBYI | Puma Biotechnology, Inc. | 479.03M | -5.50% | 475,938 | 231.24M |
| 235 | CTNM | Contineum Therapeutics, Inc. | 470.64M | -6.64% | 550,258 | - |
| 236 | PRTA | Prothena Corporation plc | 445.60M | -3.45% | 357,843 | 54.53M |
| 237 | PRLD | Prelude Therapeutics Incorporated | 443.91M | -11.13% | 704,937 | 22.42M |
| 238 | EIKN | Eikon Therapeutics, Inc. | 440.36M | -9.47% | 727,440 | - |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 437.23M | -5.86% | 1,032,183 | - |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 423.48M | -6.38% | 232,335 | - |
| 241 | RZLT | Rezolute, Inc. | 417.87M | -0.99% | 1,683,275 | - |
| 242 | SPRY | ARS Pharmaceuticals, Inc. | 415.69M | -6.70% | 1,370,353 | 116.93M |
| 243 | ZURA | Zura Bio Limited | 414.94M | -3.99% | 2,062,390 | - |
| 244 | EDIT | Editas Medicine, Inc. | 413.13M | -7.88% | 5,166,778 | 47.01M |
| 245 | GALT | Galectin Therapeutics Inc. | 408.44M | -2.17% | 174,132 | - |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 407.68M | -2.83% | 174,142 | - |
| 247 | LRMR | Larimar Therapeutics, Inc. | 403.44M | 1.18% | 2,718,707 | - |
| 248 | RLMD | Relmada Therapeutics, Inc. | 403.21M | -10.85% | 1,130,083 | - |
| 249 | TTRX | Turn Therapeutics Inc. | 402.44M | -11.64% | 101,576 | - |
| 250 | IRD | Opus Genetics, Inc. | 401.84M | -6.40% | 3,055,681 | 9.86M |
| 251 | VOGX | Vogenx, Inc. | 399.01M | 1.09% | 53,379 | - |
| 252 | IKT | Inhibikase Therapeutics, Inc. | 391.46M | -6.93% | 412,348 | 1.00 |
| 253 | VTVT | vTv Therapeutics Inc. | 379.95M | -1.67% | 18,896 | 36.84M |
| 254 | CCCC | C4 Therapeutics, Inc. | 378.92M | -6.95% | 4,594,763 | 35.04M |
| 255 | AGEN | Agenus Inc. | 378.17M | -3.45% | 610,168 | 132.69M |
| 256 | ARCT | Arcturus Therapeutics Holdings Inc. | 378.03M | -7.51% | 1,076,876 | 29.37M |
| 257 | ARTV | Artiva Biotherapeutics, Inc. | 377.43M | -4.57% | 407,795 | 251.00K |
| 258 | CABA | Cabaletta Bio, Inc. | 376.39M | -11.20% | 8,677,229 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 368.56M | -4.54% | 141,625 | 59.22M |
| 260 | OBIO | Orchestra BioMed Holdings, Inc. | 356.42M | -4.66% | 242,361 | 31.98M |
| 261 | ENTA | Enanta Pharmaceuticals, Inc. | 348.05M | -3.78% | 206,322 | 65.26M |
| 262 | BNTC | Benitec Biopharma Inc. | 342.90M | -10.23% | 644,179 | - |
| 263 | OCGN | Ocugen, Inc. | 339.11M | -3.85% | 12,171,357 | 4.58M |
| 264 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 333.52M | -10.73% | 540,246 | - |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 331.52M | -9.85% | 2,778,235 | - |
| 266 | EYPT | EyePoint, Inc. | 320.71M | -8.60% | 2,022,398 | 2.79M |
| 267 | IPSC | Century Therapeutics, Inc. | 318.69M | -6.88% | 508,108 | 109.16M |
| 268 | EVMN | Evommune, Inc. | 318.28M | -8.65% | 872,395 | 10.00M |
| 269 | ABEO | Abeona Therapeutics Inc. | 316.23M | -4.98% | 1,190,094 | 25.52M |
| 270 | SABS | SAB Biotherapeutics, Inc. | 308.44M | -3.14% | 406,673 | 114.70K |
| 271 | XFOR | X4 Pharmaceuticals, Inc. | 308.35M | -9.33% | 2,309,554 | 15.85M |
| 272 | VNDA | Vanda Pharmaceuticals Inc. | 304.73M | -3.26% | 904,770 | 215.72M |
| 273 | CUVL | Clinuvel Pharmaceuticals Limited | 294.04M | -0.17% | 8,326 | 65.05M |
| 274 | FATE | Fate Therapeutics, Inc. | 291.16M | -5.81% | 909,697 | 6.49M |
| 275 | FULC | Fulcrum Therapeutics, Inc. | 290.69M | -0.78% | 1,194,426 | 80.00M |
| 276 | IFRX | InflaRx N.V. | 288.84M | -5.77% | 564,759 | -11.54K |
| 277 | LXEO | Lexeo Therapeutics, Inc. | 288.79M | -13.51% | 2,425,385 | - |
| 278 | QTTB | Q32 Bio Inc. | 284.60M | -9.56% | 828,917 | 53.74M |
| 279 | UPB | Upstream Bio, Inc. | 284.26M | -5.46% | 552,994 | 3.16M |
| 280 | IMRX | Immuneering Corporation | 283.37M | -4.99% | 552,688 | - |
| 281 | ACIU | AC Immune SA | 281.38M | 3.66% | 492,823 | 21.67M |
| 282 | VCRE | Vicore Pharma Holding AB (publ) | 279.26M | -3.54% | 101,709 | 412.09K |
| 283 | PALI | Palisade Bio, Inc. | 278.83M | -5.33% | 2,945,985 | 500.00K |
| 284 | IVVD | Invivyd, Inc. | 272.09M | -4.24% | 6,910,187 | 58.37M |
| 285 | ZNTL | Zentalis Pharmaceuticals, Inc. | 271.71M | -6.82% | 1,453,568 | 26.87M |
| 286 | PYXS | Pyxis Oncology, Inc. | 268.57M | -4.02% | 433,865 | 11.04M |
| 287 | STRO | Sutro Biopharma, Inc. | 260.82M | -2.48% | 294,017 | 45.70M |
| 288 | YARW | Yarrow Bioscience, Inc. | 259.41M | -2.79% | 102,302 | - |
| 289 | LYEL | Lyell Immunopharma, Inc. | 258.04M | -5.56% | 161,497 | 27.00K |
| 290 | GLSI | Greenwich LifeSciences, Inc. | 257.02M | -10.11% | 187,140 | - |
| 291 | BCYC | Bicycle Therapeutics plc | 251.97M | -3.49% | 374,248 | 61.21M |
| 292 | SION | Sionna Therapeutics, Inc. | 249.12M | -8.47% | 1,669,507 | - |
| 293 | MGNX | MacroGenics, Inc. | 242.06M | -7.77% | 524,592 | 175.14M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 241.96M | -8.01% | 2,630,849 | 13.08M |
| 295 | PRQR | ProQR Therapeutics N.V. | 239.91M | -10.53% | 1,136,991 | 21.05M |
| 296 | RNAC | Cartesian Therapeutics, Inc. | 238.11M | -2.60% | 117,046 | 1.48M |
| 297 | TRDA | Entrada Therapeutics, Inc. | 234.37M | -3.13% | 282,769 | 4.69M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 233.44M | -10.36% | 192,932 | 4.22M |
| 299 | KROS | Keros Therapeutics, Inc. | 230.59M | -0.85% | 157,540 | 15.01M |
| 300 | CUE | Cue Biopharma, Inc. | 230.35M | 2.62% | 696,484 | 37.66M |
| 301 | FHTX | Foghorn Therapeutics Inc. | 229.82M | -8.73% | 1,795,706 | 36.74M |
| 302 | YDES | YD Bio Limited | 228.79M | 14.54% | 359,178 | 1.24M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 225.60M | -1.41% | 586,410 | 80.62M |
| 304 | ALEC | Alector, Inc. | 225.55M | 0.50% | 1,182,750 | 13.86M |
| 305 | CGEN | Compugen Ltd. | 221.65M | -6.02% | 288,332 | 74.00M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 221.25M | -5.88% | 1,322,972 | - |
| 307 | AVXL | Anavex Life Sciences Corp. | 217.84M | -4.86% | 779,168 | - |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 217.77M | -5.45% | 248,454 | 7.15M |
| 309 | NGEN | NervGen Pharma Corp. | 210.74M | -5.08% | 536,653 | - |
| 310 | CMPX | Compass Therapeutics, Inc. | 210.70M | -5.65% | 7,693,256 | 850.00K |
| 311 | TARA | Protara Therapeutics, Inc. | 209.20M | -3.80% | 882,844 | - |
| 312 | ALXO | ALX Oncology Holdings Inc. | 203.27M | -8.13% | 1,277,331 | - |
| 313 | ADAG | Adagene Inc. | 199.42M | -8.05% | 208,024 | 9.29M |
| 314 | NKTX | Nkarta, Inc. | 197.68M | -6.44% | 1,091,386 | - |
| 315 | VRXA | Veraxa Biotech AG | 196.56M | -1.42% | 43,365 | 29.54K |
| 316 | ORMP | Oramed Pharmaceuticals Inc. | 196.34M | -0.63% | 134,796 | 2.00M |
| 317 | SLGL | Sol-Gel Technologies Ltd. | 195.49M | -2.03% | 70,680 | 1.80M |
| 318 | CHRS | Coherus Oncology, Inc. | 194.67M | -3.08% | 1,617,124 | 50.94M |
| 319 | ACOG | Alpha Cognition Inc. | 191.21M | -1.90% | 59,045 | 15.26M |
| 320 | SRZN | Surrozen, Inc. | 189.94M | -8.18% | 115,543 | 11.51M |
| 321 | PEPG | PepGen Inc. | 188.39M | -8.72% | 717,229 | - |
| 322 | MSLE | Satellos Bioscience Inc. | 183.18M | -5.19% | 42,991 | - |
| 323 | ANTX | AN2 Therapeutics, Inc. | 182.27M | - | 306,158 | - |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 178.49M | -8.57% | 535,340 | 1.50M |
| 325 | NBP | NovaBridge Biosciences | 177.48M | -3.77% | 593,308 | - |
| 326 | VYGR | Voyager Therapeutics, Inc. | 176.84M | -8.60% | 690,915 | 34.46M |
| 327 | MDWD | MediWound Ltd. | 176.23M | -2.15% | 73,153 | 11.86M |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 175.63M | -3.31% | 913,585 | 29.10M |
| 329 | DTIL | Precision BioSciences, Inc. | 175.55M | -11.54% | 355,965 | 45.06M |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 166.69M | -13.02% | 471,447 | - |
| 331 | NERV | Minerva Neurosciences, Inc. | 166.64M | -8.40% | 130,458 | - |
| 332 | IPHA | Innate Pharma S.A. | 162.70M | -2.22% | 23,674 | 11.21M |
| 333 | OTLK | Outlook Therapeutics, Inc. | 161.09M | -4.96% | 2,932,303 | -1.16M |
| 334 | MENS | Jyong Biotech Ltd. | 158.86M | -10.08% | 68,747 | - |
| 335 | HUMA | Humacyte, Inc. | 157.15M | -2.93% | 3,431,573 | 2.12M |
| 336 | MOLN | Molecular Partners AG | 156.00M | 0.94% | 286 | 856.30K |
| 337 | CDXS | Codexis, Inc. | 151.12M | -0.72% | 627,710 | 77.68M |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.70M | -1.78% | 787,819 | - |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 148.28M | -3.06% | 2,920,378 | 1.34M |
| 340 | KRRO | Korro Bio, Inc. | 144.75M | -4.93% | 224,716 | 2.38M |
| 341 | RNA | Atrium Therapeutics, Inc. | 142.49M | -9.65% | 434,525 | 35.84M |
| 342 | SPRB | Spruce Biosciences, Inc. | 142.02M | -1.15% | 174,771 | 697.00K |
| 343 | CRBU | Caribou Biosciences, Inc. | 138.30M | -3.73% | 700,030 | 10.04M |
| 344 | MNOV | MediciNova, Inc. | 137.82M | -3.45% | 396,353 | 920.48K |
| 345 | NMRA | Neumora Therapeutics, Inc. | 137.41M | -6.06% | 1,692,160 | - |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 136.71M | -4.82% | 552,500 | 3.39M |
| 347 | TLSA | Tiziana Life Sciences Ltd | 135.77M | 17.99% | 1,581,126 | - |
| 348 | ARMP | Armata Pharmaceuticals, Inc. | 135.34M | -13.33% | 287,063 | 5.54M |
| 349 | ENGN | enGene Therapeutics Inc. | 134.03M | -2.44% | 669,455 | - |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 133.98M | -3.02% | 771,816 | - |
| 351 | KZIA | Kazia Therapeutics Limited | 131.56M | -12.09% | 531,021 | 1.27M |
| 352 | HURA | TuHURA Biosciences, Inc. | 130.64M | -3.76% | 185,515 | - |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 129.25M | -3.10% | 3,031,096 | 65.34K |
| 354 | IMUX | Immunic, Inc. | 127.85M | -13.56% | 662,385 | - |
| 355 | TVGN | Tevogen Inc. | 122.90M | - | - | - |
| 356 | AARD | Aardvark Therapeutics, Inc. | 121.68M | -3.30% | 54,836 | - |
| 357 | MIST | Milestone Pharmaceuticals Inc. | 121.47M | -6.41% | 1,529,135 | 2.34M |
| 358 | NAUT | Nautilus Biotechnology, Inc. | 121.39M | -4.55% | 386,715 | 190.00K |
| 359 | OKUR | OnKure Therapeutics, Inc. | 119.06M | -5.16% | 149,747 | - |
| 360 | CNXU | Conexeu Sciences Inc. | 118.75M | -4.32% | 235,356 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 118.23M | -4.91% | 158,612 | 8.02M |
| 362 | LENZ | LENZ Therapeutics, Inc. | 118.14M | -8.96% | 765,642 | 21.48M |
| 363 | CBUS | Cibus, Inc. | 117.70M | -3.14% | 46,369 | 4.35M |
| 364 | PMN | ProMIS Neurosciences, Inc. | 116.04M | -4.71% | 43,688 | - |
| 365 | GNLX | Genelux Corporation | 112.70M | -3.64% | 115,793 | 8.00K |
| 366 | EQ | Equillium, Inc. | 110.96M | -9.33% | 504,604 | 4.39M |
| 367 | VANI | Vivani Medical, Inc. | 110.95M | -3.15% | 149,086 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 109.16M | -4.04% | 613,849 | 70.00M |
| 369 | TENX | Tenax Therapeutics, Inc. | 108.84M | -2.06% | 2,353,049 | - |
| 370 | PYPD | PolyPid Ltd. | 107.04M | -3.30% | 69,131 | - |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 106.92M | -1.40% | 648,576 | 4.88M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 106.67M | -0.47% | 54,571 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 104.38M | -15.29% | 9,301,263 | - |
| 374 | PMVP | PMV Pharmaceuticals, Inc. | 103.45M | -9.27% | 574,275 | - |
| 375 | CLLS | Cellectis S.A. | 102.71M | -7.69% | 169,806 | 63.82M |
| 376 | CRDF | Cardiff Oncology, Inc. | 101.91M | -1.50% | 590,222 | 508.00K |
| 377 | SEER | Seer, Inc. | 99.67M | -3.23% | 157,127 | 14.22M |
| 378 | ANIX | Anixa Biosciences, Inc. | 95.60M | -1.43% | 391,158 | - |
| 379 | NRXS | NeurAxis, Inc. | 91.80M | - | 58,037 | 5.32M |
| 380 | ACET | Adicet Bio, Inc. | 91.39M | -7.21% | 263,246 | - |
| 381 | ICCC | ImmuCell Corporation | 90.73M | - | 7,866 | 30.68M |
| 382 | CGTX | Cognition Therapeutics, Inc. | 90.34M | -3.19% | 563,701 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 90.05M | 1.20% | 34,926 | 43.30M |
| 384 | RLYB | Rallybio Corporation | 89.54M | -0.35% | 5,340 | 646.00K |
| 385 | NTRB | Nutriband Inc. | 89.34M | 8.73% | 129,732 | 1.62M |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 88.28M | -4.19% | 435,424 | - |
| 387 | ONCY | Oncolytics Biotech Inc. | 86.26M | -5.16% | 1,891,093 | - |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 85.92M | -4.14% | 40,473 | 6.19M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 83.91M | -2.40% | 34,647 | - |
| 390 | ALDX | Aldeyra Therapeutics, Inc. | 81.44M | -3.23% | 633,727 | - |
| 391 | GANX | Gain Therapeutics, Inc. | 80.30M | -5.64% | 292,878 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 80.29M | -3.65% | 627,035 | - |
| 393 | IBIO | iBio, Inc. | 80.06M | -6.39% | 363,824 | 100.00K |
| 394 | NTHI | NeOnc Technologies Holdings, Inc. | 80.04M | -6.67% | 95,960 | 39.99K |
| 395 | VRCA | Verrica Pharmaceuticals Inc. | 79.37M | -2.12% | 41,334 | 30.32M |
| 396 | FBIO | Fortress Biotech, Inc. | 78.04M | -4.49% | 331,816 | 68.47M |
| 397 | GUTS | Fractyl Health, Inc. | 77.30M | -12.19% | 4,726,577 | 3.00K |
| 398 | OSTX | OS Therapies Incorporated | 76.11M | -6.78% | 654,500 | - |
| 399 | KLRS | Kalaris Therapeutics, Inc. | 74.27M | -3.70% | 24,130 | - |
| 400 | RNXT | RenovoRx, Inc. | 73.56M | -4.12% | 765,010 | 1.98M |
| 401 | SPRO | Spero Therapeutics, Inc. | 73.38M | -7.35% | 1,403,213 | 47.00M |
| 402 | CING | Cingulate Inc. | 72.42M | -3.30% | 119,519 | - |
| 403 | CSBR | Champions Oncology, Inc. | 69.87M | -5.10% | 1,502 | 60.66M |
| 404 | PLRX | Pliant Therapeutics, Inc. | 69.66M | -1.32% | 254,282 | - |
| 405 | OKYO | OKYO Pharma Limited | 69.27M | -2.22% | 85,222 | - |
| 406 | BSEM | BioStem Technologies, Inc. | 67.83M | -4.52% | 84,032 | 34.59M |
| 407 | CNTB | Connect Biopharma Holdings Limited | 67.38M | -11.93% | 1,410,191 | 2.95M |
| 408 | GOSS | Gossamer Bio, Inc. | 67.16M | -5.99% | 455,817 | 53.29M |
| 409 | ATHE | Alterity Therapeutics Limited | 66.83M | -6.08% | 15,660 | 2.50M |
| 410 | ALPS | Alps Group Inc | 66.56M | 0.03% | 46,885 | 3.74M |
| 411 | XBIT | XBiotech Inc. | 66.46M | - | 40,037 | - |
| 412 | RNTX | Rein Therapeutics Inc. | 66.45M | -3.07% | 441,403 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 65.31M | -6.08% | 229,932 | 11.57M |
| 414 | INKT | MiNK Therapeutics, Inc. | 63.02M | 1.98% | 14,810 | - |
| 415 | ELOX | Eloxx Pharmaceuticals, Inc. | 62.30M | -7.74% | 20,262 | - |
| 416 | BOLD | Boundless Bio, Inc. | 61.42M | -6.25% | 170,129 | - |
| 417 | CLNN | Clene Inc. | 60.98M | -2.05% | 75,251 | 197.00K |
| 418 | HYPD | Hyperion DeFi, Inc. | 60.91M | -1.75% | 409,631 | 1.40M |
| 419 | EXOZ | eXoZymes, Inc. | 59.22M | 3.07% | 11,914 | -700.00 |
| 420 | XLO | Xilio Therapeutics, Inc. | 58.83M | -1.11% | 1,276 | 64.09M |
| 421 | IBO | Impact BioMedical Inc. | 56.65M | -0.45% | 40,517 | 35.00K |
| 422 | SER | Serina Therapeutics, Inc. | 55.63M | -5.19% | 8,946 | 130.00K |
| 423 | INMB | INmune Bio Inc. | 55.51M | -7.41% | 487,604 | 50.00K |
| 424 | LONA | LeonaBio, Inc. | 55.49M | -2.64% | 21,397 | - |
| 425 | HRTX | Heron Therapeutics, Inc. | 55.25M | -2.68% | 1,718,619 | 151.18M |
| 426 | IMA | ImageneBio, Inc. | 54.94M | -0.21% | 1,479 | 800.00K |
| 427 | MREO | Mereo BioPharma Group plc | 54.34M | 7.59% | 3,930,725 | 500.00K |
| 428 | ANVS | Annovis Bio, Inc. | 54.11M | 0.79% | 1,145,513 | - |
| 429 | EDSA | Edesa Biotech, Inc. | 53.64M | -2.46% | 25,466 | - |
| 430 | APLM | Apollomics, Inc. | 51.39M | -1.35% | 24,955 | 8.84M |
| 431 | DWTX | Dogwood Therapeutics, Inc. | 51.33M | - | 23,693 | - |
| 432 | ELTX | Elicio Therapeutics, Inc. | 49.15M | - | 195,353 | - |
| 433 | TIL | Instil Bio, Inc. | 49.07M | 1.47% | 11,585 | - |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 48.08M | 0.75% | 316,709 | 21.00M |
| 435 | PDSB | PDS Biotechnology Corporation | 46.11M | -9.46% | 9,724,154 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.60M | -0.93% | 193,893 | - |
| 437 | MGX | Metagenomi Therapeutics, Inc. | 42.69M | -0.88% | 100,338 | 13.56M |
| 438 | IMMP | Immutep Limited | 42.55M | -6.00% | 751,518 | 13.79M |
| 439 | FLNA | Filana Therapeutics, Inc. | 42.03M | -15.52% | 5,466,860 | - |
| 440 | VERU | Veru Inc. | 41.94M | -1.60% | 94,859 | 16.89M |
| 441 | LITS | Lite Strategy, Inc. | 40.15M | -9.23% | 585,001 | - |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 39.69M | -3.85% | 957,509 | 146.62M |
| 443 | CRVO | CervoMed Inc. | 37.95M | -0.79% | 123,578 | 331.30K |
| 444 | MCRB | Seres Therapeutics, Inc. | 37.68M | -5.72% | 51,648 | 1.88M |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 37.10M | 0.85% | 130,428 | 35.09M |
| 446 | ATYR | aTyr Pharma, Inc. | 36.80M | 5.27% | 1,198,110 | 190.00K |
| 447 | CNTX | Context Therapeutics Inc. | 35.15M | -1.67% | 1,107,087 | - |
| 448 | BCTX | BriaCell Therapeutics Corp. | 34.93M | -1.96% | 65,891 | - |
| 449 | ALGS | Aligos Therapeutics, Inc. | 34.72M | -2.11% | 35,074 | 31.52M |
| 450 | NNVC | NanoViricides, Inc. | 34.40M | -1.31% | 316,672 | - |
| 451 | CELU | Celularity Inc. | 33.29M | -2.54% | 77,117 | 26.55M |
| 452 | QNRX | Quoin Pharmaceuticals, Ltd. | 32.43M | -3.71% | 39,416 | - |
| 453 | QNTM | Quantum BioPharma Ltd. | 31.38M | 4.86% | 645,261 | - |
| 454 | QNCX | Quince Therapeutics, Inc. | 30.66M | -3.83% | 7,589 | - |
| 455 | BYSI | BeyondSpring Inc. | 29.88M | -1.85% | 13,389 | 1.88M |
| 456 | IGC | IGC Pharma, Inc. | 29.58M | 1.10% | 550,383 | 1.11M |
| 457 | ABVC | ABVC BioPharma, Inc. | 29.55M | -1.72% | 75,363 | 797.92K |
| 458 | CVM | CEL-SCI Corporation | 29.55M | -1.18% | 171,391 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 29.36M | -0.41% | 29,103 | 4.62M |
| 460 | RNAZ | TransCode Therapeutics, Inc. | 28.44M | -5.08% | 425,715 | - |
| 461 | EVAX | Evaxion A/S | 27.36M | 0.31% | 35,211 | 7.49M |
| 462 | GRDX | GridAI Technologies Corp. | 27.33M | -0.77% | 30,450 | - |
| 463 | PLRZ | Polyrizon Ltd. | 26.81M | 4.69% | 40,063 | - |
| 464 | TCRX | TScan Therapeutics, Inc. | 24.67M | 2.59% | 1,081,195 | 7.11M |
| 465 | PBM | Psyence Biomedical Ltd. | 24.07M | 3.44% | 295,247 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 22.92M | - | 26,056 | 330.00K |
| 467 | NXTC | NextCure, Inc. | 22.06M | -6.95% | 225,869 | - |
| 468 | ATOS | Atossa Therapeutics, Inc. | 21.75M | -3.54% | 37,188 | - |
| 469 | RADX | Radiopharm Theranostics Limited | 21.38M | -1.52% | 35,680 | 9.34M |
| 470 | MRKR | Marker Therapeutics, Inc. | 20.67M | 1.64% | 64,907 | 3.55M |
| 471 | ESLA | Estrella Immunopharma, Inc. | 20.53M | -2.68% | 32,319 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 19.91M | -1.47% | 15,483 | 1.17M |
| 473 | CLRB | Cellectar Biosciences, Inc. | 19.75M | -6.28% | 72,944 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 18.86M | -9.01% | 429,033 | - |
| 475 | AKTX | Akari Therapeutics, Plc | 18.81M | -3.88% | 86,423 | - |
| 476 | PTN | Palatin Technologies, Inc. | 17.79M | - | 41,214 | 12.88M |
| 477 | LTRN | Lantern Pharma Inc. | 17.77M | 2.21% | 292,344 | - |
| 478 | TVRD | Tvardi Therapeutics, Inc. | 17.61M | -15.92% | 412,746 | - |
| 479 | ACTU | Actuate Therapeutics, Inc. | 17.57M | -9.39% | 223,239 | - |
| 480 | LPCN | Lipocine Inc. | 17.48M | -1.85% | 90,867 | 1.57M |
| 481 | KTTA | Pasithea Therapeutics Corp. | 17.13M | -0.27% | 114,005 | - |
| 482 | KPRX | Kiora Pharmaceuticals, Inc. | 16.67M | -3.32% | 10,131 | 20.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 16.55M | -6.31% | 167,750 | 345.00K |
| 484 | CMMB | Chemomab Therapeutics Ltd. | 16.52M | -4.20% | 133,517 | - |
| 485 | NCEL | NewcelX Ltd. | 16.52M | -5.80% | 9,281 | - |
| 486 | VTGN | Vistagen Therapeutics, Inc. | 16.35M | 46.54% | 574,960,002 | 2.50M |
| 487 | PASG | Passage Bio, Inc. | 16.09M | 1.01% | 3,445 | - |
| 488 | BCDA | BioCardia, Inc. | 15.90M | - | 141,358 | 3.00K |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 15.61M | -4.95% | 223,139 | 7.11M |
| 490 | ICU | SeaStar Medical Holding Corporation | 15.56M | - | 11,554 | 1.71M |
| 491 | TPST | Tempest Therapeutics, Inc. | 15.25M | -7.80% | 791,836 | - |
| 492 | DYAI | Dyadic International, Inc. | 15.12M | 3.72% | 251,326 | 3.80M |
| 493 | CNSY | Cerenome, Inc. | 14.80M | -3.94% | 66,314 | 4.20M |
| 494 | HIND | Vyome Holdings, Inc. | 14.11M | 3.08% | 5,462 | 129.73K |
| 495 | NIKI | Niki BioSolutions, Inc. | 13.75M | -2.90% | 7,114 | - |
| 496 | NRSN | NeuroSense Therapeutics Ltd. | 13.68M | 3.06% | 8,761 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 13.39M | 2.24% | 4,117 | - |
| 498 | AEON | AEON Biopharma, Inc. | 13.16M | 0.73% | 1,287,777 | - |
| 499 | PLUR | Pluri Inc. | 13.09M | -3.64% | 14,812 | 1.02M |
| 500 | MLEC | Moolec Science SA | 13.02M | 12.79% | 23,860 | 7.83M |